Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "GE-HealthCare"

43 News Found

Wipro GE Healthcare launches facility under govt’s PLI scheme
News | April 01, 2022

Wipro GE Healthcare launches facility under govt’s PLI scheme

It is one of the 15 medical device manufacturers approved under the government’s PLI scheme


Dr Shravan Subramanyam, MD, Wipro GE Healthcare elected NATHEALTH President
News | April 01, 2022

Dr Shravan Subramanyam, MD, Wipro GE Healthcare elected NATHEALTH President

Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India


Wipro GE Healthcare bolsters leadership bench in India & South Asia
People | March 23, 2022

Wipro GE Healthcare bolsters leadership bench in India & South Asia

This announcement comes after the formation of a new Intercontinental Region within GE Healthcare, led by Chaillot


Wipro GE Healthcare introduces remote monitoring solution for COVID 19
Healthcare | August 04, 2021

Wipro GE Healthcare introduces remote monitoring solution for COVID 19

Apollo hospital-Hyderabad, Kainos Hospital-Rohtak and Apex Hospital Jaipur have deployed this solution


GSK and Fleming Initiative launch bold new fight against antimicrobial resistance
R&D | November 21, 2025

GSK and Fleming Initiative launch bold new fight against antimicrobial resistance

These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections


Medanta Super Speciality Hospital to set up new hospital in Guwahati
Hospitals | November 02, 2025

Medanta Super Speciality Hospital to set up new hospital in Guwahati

The upcoming state-of-the art 400+ bed facility is set to come up at an approximate cost of Rs 500 crore


Moderna’s mRNA-4359 shows promising early results in resistant Melanoma at ESMO 2025
Clinical Trials | October 13, 2025

Moderna’s mRNA-4359 shows promising early results in resistant Melanoma at ESMO 2025

mRNA-4359 advances to phase 2 following encouraging results in checkpoint inhibitor-resistant Melanoma


Lilly to invest $1 billion+ in new contract manufacturing in India
News | October 06, 2025

Lilly to invest $1 billion+ in new contract manufacturing in India

Investment to expand manufacturing and global medicine supply capacity